Nothing Special   »   [go: up one dir, main page]

CN109809987A - A kind of new synthetic method of loxoprofen sodium - Google Patents

A kind of new synthetic method of loxoprofen sodium Download PDF

Info

Publication number
CN109809987A
CN109809987A CN201711166565.7A CN201711166565A CN109809987A CN 109809987 A CN109809987 A CN 109809987A CN 201711166565 A CN201711166565 A CN 201711166565A CN 109809987 A CN109809987 A CN 109809987A
Authority
CN
China
Prior art keywords
toluene
synthetic method
room temperature
sodium
loxoprofen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201711166565.7A
Other languages
Chinese (zh)
Inventor
宫宁瑞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Panjin Gelin Kaimo Technology Co Ltd
Original Assignee
Panjin Gelin Kaimo Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Panjin Gelin Kaimo Technology Co Ltd filed Critical Panjin Gelin Kaimo Technology Co Ltd
Priority to CN201711166565.7A priority Critical patent/CN109809987A/en
Publication of CN109809987A publication Critical patent/CN109809987A/en
Pending legal-status Critical Current

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention belongs to organic synthesis fields, and in particular to a kind of new synthetic method of loxoprofen sodium.The synthetic method synthetic method is reacted through 4 steps and is made using 2- (4- bromomethyl) phenylpropionic acid as raw material.The present invention uses a kind of new synthetic method of loxoprofen sodium, and yield improves, and industrial prospect is good.

Description

A kind of new synthetic method of loxoprofen sodium
Technical field
The invention belongs to organic synthesis fields, and in particular to a kind of new synthetic method of loxoprofen sodium.
Background technique
Loxoprofen sodium (1oxoprofen sodium) is a kind of important 2- phenylpropionic acid Nonsteroidal anti-inflammatory analgesia Medicine is listed by total company, Japan three in exploitation in 1986, anti-inflammatory, analgesia, refrigeration function with higher, and alimentary canal is bad React small.Compared with clinically similar drugs, feature is mainly reflected in loxoprofen sodium: stronger (clinical effectiveness is good), faster (taking orally 30 minutes plasma concentration, that is, reach to peak values), safer (Small side effects).Another kind of feature is wide indications, clinically can be wide After the general anti-inflammatory and antalgic for being used for rheumatoid arthritis, pain in the loins, scapulohumeral periarthritis, neck shoulder wrist syndrome etc., operation, wound and after extraction Easing pain and diminishing inflammation and the antipyretic-antalgic of acute upper respiratory tract inflammation etc..
Currently, the synthetic route of loxoprofen sodium is mostly more complicated, synthesis yield is low, and bulk pharmaceutical chemicals are expensive and are not easy It obtains.
Summary of the invention
The purpose of the present invention is to provide a kind of new synthetic method of loxoprofen sodium, this method high income, synthesis is simple, It is suitble to industrialized production.
To achieve the goals above, the present invention adopts the following technical scheme: a kind of new synthetic method of loxoprofen sodium, is somebody's turn to do Synthetic method is reacted through 4 steps and is made using 2- (4- bromomethyl) phenylpropionic acid as raw material.
A kind of new synthetic method of loxoprofen sodium, the synthetic method include the following steps:
Step 1: by 24.3 g 2- (4- bromomethyl) phenylpropionic acid, 64 g methanol investment reaction flask, stirring evenly, 0 The 19.6 g concentrated sulfuric acids are added dropwise at~5 DEG C, 50 m L water are added, with 200 m L toluene in 6 h that are added dropwise that the reaction was continued Extraction, layering, organic layer are washed with saturated sodium carbonate solution, are washed to neutrality, dry, are concentrated to dryness, are obtained 25.2 g Compound 2- (4- 2-bromomethylphenyl) methyl propionate (I);Step 2: by l5.7 g 2- carbethoxyl group cyclopentanone, 50 m L Toluene is put into reaction flask, is stirred evenly, and 5.2 g of potassium carbonate is added, and is warming up to reflux, and the 50 above-mentioned preparations of m L are added dropwise 25.7 g compound I toluene solution, drop finishes, continues to be stirred to react 12 h, be down to room temperature, 50 m L water are added, point Layer, water layer is 3.0-4.0 with 8.0 m olL salt acid for adjusting pH value, is extracted with 50 lnL toluene, and toluene is washed Layer, reduced pressure are evaporated off toluene, obtain 29 g compound 2- [4- (1- carbethoxyl group -2- oxo -1- cyclopentyl-methyl) benzene Base] methyl propionate (II);Step 3: being 48% hydrobromic acid, 30 mL by 31.8 g compound II, 70 mL mass fractions Glacial acetic acid is put into reaction flask, and 8 h of back flow reaction is cooled to room temperature, and 50 mL water are added, and is extracted with 100 mL toluene, Toluene layer saturated common salt water washing, is concentrated to dryness, with ethyl acetate-hexane (volume ratio 1:2) crystallization, mistake It is sour (III) to obtain 20g loxoprofen for filter, drying;
Step 4: 24.6 g loxoprofens sour (III), 100 mL ethyl alcohol being placed in a reaction flask, 2 mol/L are added dropwise at room temperature Sodium hydrate aqueous solution to pH value be 7.0-8.0, drop finishes, and is stirred at room temperature 3 h, and crystallization, filtering obtains crude product, uses Ethyl alcohol-isopropyl ether recrystallization, obtains loxoprofen sodium.
Compared with prior art, effect of the invention is that: the present invention use loxoprofen sodium new method, not only reduce Cost protects environment, and easy to operate, convenient post-treatment, high income, and synthesis is simple, is suitble to industrialized production.
Specific embodiment
Embodiment 1
A kind of new synthetic method of loxoprofen sodium, the synthetic method include the following steps:
Step 1: by 24.3 g 2- (4- bromomethyl) phenylpropionic acid, 64 g methanol investment reaction flask, stirring evenly, 0 The 19.6 g concentrated sulfuric acids are added dropwise at~5 DEG C, 50 m L water are added, with 200 m L toluene in 6 h that are added dropwise that the reaction was continued Extraction, layering, organic layer are washed with saturated sodium carbonate solution, are washed to neutrality, dry, are concentrated to dryness, are obtained 25.2 g Compound 2- (4- 2-bromomethylphenyl) methyl propionate (I) is colourless oil liquid, yield 98%, H PL C detection purity It is 96%.
1H-NMR (CDCl3): 1.47 (Hz of d, 3H, J=7.5), 3.63 (S, 3H), 3.72 (q, H, J= 7.5 Hz), 4.45 (S, 2H), 7.26 (dd, 2H, J=1.5,6.5 H z), 7.33 (dd, 2H, J=1.5, 6.5 Hz) .Step 2: by l5.7 g 2- carbethoxyl group cyclopentanone, 50 m L toluene investment reaction flask, stir evenly, 5.2 g of potassium carbonate is added, is warming up to reflux, the toluene solution of 25.7 g compound I of the 50 above-mentioned preparations of m L, drop is added dropwise Finish, continue to be stirred to react 12 h, be down to room temperature, 50 m L water, layering, 8.0 m olL hydrochloric acid tune of water layer are added Section pH value is 3.0-4.0, is extracted with 50 mL toluene, and toluene layer is washed, and reduced pressure is evaporated off toluene, obtains 29 g Compound 2- [4- (1- carbethoxyl group -2- oxo -1- cyclopentyl-methyl) phenyl] methyl propionate (II) is yellow oily liquid , it is 92% that yield 9l%, H PLC, which detects purity,;
1H-NMR (CDCl3): 1.25 (Hz of d, 3H, J=7.5), 1.47 (H z of d, 3H, J=7.0), 1.63- 1.65 (m, 1H), 1. 89-1.96 (m, 2H), 2.03~2.O7 (m, 1H), 2.39-2.43 (m, 2H ), 3.o6 (I-Iz of d, 1H, J=14.0), 3.19 (d, 1H ,=l3.5 H z), 3.65 (S, 3H), 3.68 (H z of q, 1H, J=7.5), 4. 16 (H z of q, 2H, J=7.5), 7.09 (d, 2H, J=8.0 H z), 7.18 (H z of d, 2H, J=8.0).
Step 3: being 48% hydrobromic acid, 30 mL glacial acetic acid investment by 31.8 g compound II, 70 mL mass fractions In reaction flask, 8 h of back flow reaction is cooled to room temperature, and 50 mL water are added, and is extracted with 100 mL toluene, and toluene layer is used full And brine It, it is concentrated to dryness, with ethyl acetate-hexane (volume ratio 1:2) crystallization, filters, drying, It is sour (III) to obtain 20g loxoprofen, is white solid, yield 81%, HPLC detection level is 98%, mp108-110 ℃ ;
1H-NMR (CDCl3): 1.49 (H z of d, 3H, J=7.0), 1.51-1.56 (m, 1H), 1.7O-1. 74 (m, 1H), 1.94-1.98 (ITI, 1H), 2.07-2.13 (m, 2H), 2.3l-2.34 (m, 2H), 2.5l (dd, 1H, J=4.0,14.0 H z), 3.13 (dd, 1H, J: 4.0,14.0 H z), 3.70 (q, 1H, J= 7.0 H z), 7.13 (H z of d, 2H, J=8.0), 7.23 (H z of d, 2H, J=8.0).
Step 4: 24.6 g loxoprofens sour (III), 100 mL ethyl alcohol being placed in a reaction flask, 2 are added dropwise at room temperature The sodium hydrate aqueous solution of mol/L to pH value is 7.0-8.0, and drop finishes, and 3 h, crystallization are stirred at room temperature, and filtering obtains slightly Product are recrystallized with ethyl alcohol-isopropyl ether, obtain 25 g of loxoprofen sodium, are white solid, yield 82%, H PLC Detection level is 196-198 DEG C of 99%, mp.
The foregoing is only a preferred embodiment of the present invention, is not intended to restrict the invention, for the skill of this field For art personnel, the invention may be variously modified and varied.All within the spirits and principles of the present invention, made any to repair Change, equivalent replacement, improvement etc., should all be included in the protection scope of the present invention.

Claims (2)

1. a kind of new synthetic method of loxoprofen sodium, which is characterized in that the synthetic method is with 2- (4- bromomethyl) phenylpropionic acid For raw material, reacts and be made through 4 steps.
2. a kind of new synthetic method of loxoprofen sodium according to claim 1, which is characterized in that the synthetic method includes Following steps:
Step 1: by 2- (4- bromomethyl) phenylpropionic acid, methanol investment reaction flask, stirring evenly, be added dropwise at 0~5 DEG C The concentrated sulfuric acid, 6 h that are added dropwise that the reaction was continued are added water, are extracted with toluene, is layered, organic layer is washed with saturated sodium carbonate solution It washs, is washed to neutrality, it is dry, it is concentrated to dryness, obtains compound 2- (4- 2-bromomethylphenyl) methyl propionate (I);
Step 2: by 2- carbethoxyl group cyclopentanone, toluene investment reaction flask, stirring evenly, potassium carbonate is added, is warming up to back The toluene solution of the compound I of above-mentioned preparation is added dropwise in stream, and drop finishes, continues to be stirred to react 12 h, is down to room temperature, and water is added, Layering, water layer is 3.0-4.0 with salt acid for adjusting pH value, is extracted with toluene, and toluene layer is washed, and toluene is evaporated off in reduced pressure, Obtain 29 g compound 2- [4- (1- carbethoxyl group -2- oxo -1- cyclopentyl-methyl) phenyl] methyl propionate (II);Step 3: by compound II, mass fraction be hydrobromic acid, glacial acetic acid is put into reaction flask, and 8 h of back flow reaction is cooled to room temperature, adds Enter water, extracted with toluene, toluene layer saturated common salt water washing is concentrated to dryness, with ethyl acetate-hexane crystallization, mistake It is sour (III) to obtain loxoprofen for filter, drying;
Step 4: loxoprofen sour (III), ethyl alcohol being placed in a reaction flask, the sodium hydrate aqueous solution being added dropwise at room temperature to pH Value is 7.0-8.0, and drop finishes, and 3 h, crystallization are stirred at room temperature, and filtering obtains crude product, is recrystallized with ethyl alcohol-isopropyl ether, obtains Lip river Suo Luofen sodium.
CN201711166565.7A 2017-11-21 2017-11-21 A kind of new synthetic method of loxoprofen sodium Pending CN109809987A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201711166565.7A CN109809987A (en) 2017-11-21 2017-11-21 A kind of new synthetic method of loxoprofen sodium

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201711166565.7A CN109809987A (en) 2017-11-21 2017-11-21 A kind of new synthetic method of loxoprofen sodium

Publications (1)

Publication Number Publication Date
CN109809987A true CN109809987A (en) 2019-05-28

Family

ID=66600367

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201711166565.7A Pending CN109809987A (en) 2017-11-21 2017-11-21 A kind of new synthetic method of loxoprofen sodium

Country Status (1)

Country Link
CN (1) CN109809987A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113387792A (en) * 2021-07-12 2021-09-14 迪嘉药业集团有限公司 Synthetic method of loxoprofen sodium process impurity
CN115974673A (en) * 2022-12-02 2023-04-18 上海奥萝拉医药科技有限公司 Novel synthesis method of loxoprofen acid

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113387792A (en) * 2021-07-12 2021-09-14 迪嘉药业集团有限公司 Synthetic method of loxoprofen sodium process impurity
CN115974673A (en) * 2022-12-02 2023-04-18 上海奥萝拉医药科技有限公司 Novel synthesis method of loxoprofen acid

Similar Documents

Publication Publication Date Title
CN102020633B (en) Method for preparing 1-(3,5- dichloropyridine-2-yl)-pyrazolecarboxamide compounds
CN101967145A (en) Method for preparing antithrombotic medicament apixaban
US20090043094A1 (en) Process for trans-4-amino-1-cyclohexanecarboxylic acid derivatives
CN104447600B (en) A kind of Preparation Method And Their Intermediate impurity of Parecoxib sodium compound, preparation method and application
CN108997253B (en) Mandelic acid derivatives containing 1,3, 4-oxadiazole thioether and application thereof
CN109809987A (en) A kind of new synthetic method of loxoprofen sodium
CN102964313B (en) Synthetic method of febuxostat
CN108864111A (en) A kind of Tr*ger ' s base class compound and the preparation method and application thereof containing benzimidazole
CN106188040B (en) A kind of Fevipiprant and its intermediate preparation method
CN103896700A (en) Preparation method of ezetimibe chiral intermediate
CN107935930A (en) 3 difluoromethyl 1H pyrazoles of a kind of 1 methyl, 4 amide derivatives and preparation method and application
CN102070484B (en) Method for preparing prilocainum or hydrochloride thereof
CN106883192B (en) The synthetic method of the benzoic acid derivative of nitrogenous class heterocyclic antineoplastic pharmaceutical actives oxazolyl modification
Kumar et al. Design and synthesis of optically pure 3-aryl-6-methyl-2-thioxotetrahydropyrimidin-4 (1 H)-ones as anti-prostate cancer agents
CN108467353B (en) Preparation method of enantiopure tert-butyl sulfinamide
CN107646855B (en) Application of thiazole compound containing piperidine in preparation of bactericide and preparation method thereof
CA2855021A1 (en) Process for the preparation of roflumilast
CN107098866A (en) The method for splitting of medicine Lesinurad axial chirality enantiomers
WO2015027893A1 (en) Dabigatran etexilate synthesizing method
CN104926807A (en) Rivaroxaban related substance 'diamine' and synthesis method thereof
CN105085371B (en) (S) { 1 (chloro-carbonic acid ester group) 2 [2 (1,3 dioxy iso-indoles) base] ethyl } halide salt and preparation method thereof
CN105218519A (en) A kind of preparation method of dabigatran etexilate intermediate
Mistry et al. Conventional and microwave induced synthesis of various pyrimidine and isoxazole derivatives from 1-{4'-[(4''-methylpiperazinyl) diazenyl] phenyl}-3-(substitutedphenyl) prop-2-en-1-one and studies of their antimicrobial activity
CN105085431B (en) 4 (4 first ammonia thiazolinyl phenyl) 3 morpholones and preparation method thereof
CN108912124A (en) A method of utilizing the ionic liquid-catalyzed preparation compound of pyrazole heterocycle containing sulfuryl

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
WD01 Invention patent application deemed withdrawn after publication
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20190528